Sort   by:  
 Page size 
UnknownSofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan.
Not available
S-EPMC8199354 | biostudies-literature
UnknownReal-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection in Taiwan.
Not available
S-EPMC8241842 | biostudies-literature
UnknownDynamics of Cardiometabolic Risk Factors Are Linked to the Risk of Hypertension and Diabetes in MASLD.
Not available
S-EPMC12694567 | biostudies-literature
UnknownAssociation Between Prenatal Exposure to Metals and Atopic Dermatitis Among Children Aged 4 Years in Taiwan.
Not available
S-EPMC8552055 | biostudies-literature
UnknownRegorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.
Not available
S-EPMC8704159 | biostudies-literature
UnknownArtificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma.
Not available
S-EPMC9827079 | biostudies-literature
UnknownTREAT-AIS: A Multicenter National Registry.
Not available
S-EPMC12778707 | biostudies-literature
UnknownTherapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort study.
Not available
S-EPMC10689175 | biostudies-literature
UnknownClinical impact of pharmacogenetic risk variants in a large chinese cohort.
Not available
S-EPMC12241563 | biostudies-literature
UnknownThe Taiwan Precision Medicine Initiative provides a cohort for large-scale studies.
Not available
S-EPMC12675286 | biostudies-literature
Sort   by:  
 Page size